A comprehensive review of SARS-CoV-2 vaccines: Pfizer, Moderna & Johnson & Johnson
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A comprehensive review of SARS-CoV-2 vaccines: Pfizer, Moderna & Johnson & Johnson
Authors
Keywords
-
Journal
Human Vaccines & Immunotherapeutics
Volume -, Issue -, Pages 1-12
Publisher
Informa UK Limited
Online
2022-02-08
DOI
10.1080/21645515.2021.2002083
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Narrative Review on Characterization of Acute Respiratory Distress Syndrome in COVID-19-infected Lungs using Artificial Intelligence
- (2021) Jasjit S. Suri et al. COMPUTERS IN BIOLOGY AND MEDICINE
- Publisher Correction: Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults
- (2021) Mark J. Mulligan et al. NATURE
- Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine
- (2021) Jerald Sadoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine — Preliminary Report
- (2021) Kai Wu et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Janssen COVID-19 Vaccine — United States, February 2021
- (2021) Sara E. Oliver et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data
- (2021) Eric J Haas et al. LANCET
- Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
- (2021) Jerald Sadoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bell's palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study
- (2021) Eric Yuk Fai Wan et al. LANCET INFECTIOUS DISEASES
- Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant
- (2021) Jamie Lopez Bernal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel
- (2021) Yinon M. Bar-On et al. NEW ENGLAND JOURNAL OF MEDICINE
- Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices — United States, July 2021
- (2021) Hannah G. Rosenblum et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in Qatar
- (2021) Patrick Tang et al. NATURE MEDICINE
- Towards effective COVID‑19 vaccines: Updates, perspectives and challenges (Review)
- (2020) Daniela Calina et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
- (2020) Lisa A. Jackson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Covid-19: Johnson and Johnson vaccine trial is paused because of unexplained illness in participant
- (2020) Elisabeth Mahase BMJ-British Medical Journal
- Anaphylaxis to the first COVID-19 vaccine: is polyethylene glycol (PEG) the culprit?
- (2020) Lene H. Garvey et al. BRITISH JOURNAL OF ANAESTHESIA
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search